|
 |
![]()
|
< back /
| 08:30 |
Introduction |
|
|
08:35
 |
Incretin Hormones: Relevance to clinical management of diabetes |
Gary Lewis, MD |
08:55
|
Advances in Oral Therapy |
Lawrence Leiter, MD |
09:15
|
Innovations in Insulin Analog Therapy |
Ronald Goldenberg, MD |
09:35
|
DREAM: Role of ACE-I in Managing Diabetes |
Hertzel Gerstein, MD |
| 09:55 |
Q and A and Panel Discussion |
All faculty |
| 10:25 |
BREAK |
|
|
10:45
|
Update on Glycemic Control: Care gap |
Amir Hanna, MD |
11:10
|
Can We Stop the Progression of Diabetes: DREAM |
Hertzel Gerstein, MD |
11:35
|
ADOPT: Are all hypoglycemic agents the same? |
Amir Hanna, MD |
| 12:00 |
Q and A and Panel Discussion |
All faculty |
| 12:30 |
LUNCH |
|
|
13:15
|
Importance of Reaching an LDL Goal |
Lawrence Leiter, MD |
13:35
|
Comprehensive Approach to Metabolic Improvement |
David Fitchett, MD |
13:55
|
Insulin Delivery - Can we do better? |
Lawrence Leiter, MD |
14:15
|
Office Approach to the Diabetic Diet |
Shelly Perry |
| 14:35 |
Q and A and Panel Discussion |
All faculty |
| 15:00 |
CLOSE |
|
|
|
|
